iomeprol has been researched along with Inflammatory Bowel Diseases in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grassi, R | 1 |
| Rambaldi, PF | 1 |
| Di Grezia, G | 1 |
| Mansi, L | 1 |
| Cuccurullo, V | 1 |
| Cirillo, A | 1 |
| Riegler, G | 1 |
| Cappabianca, S | 1 |
| Rotondo, A | 1 |
1 other study available for iomeprol and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Inflammatory bowel disease: value in diagnosis and management of MDCT-enteroclysis and 99mTc-HMPAO labeled leukocyte scintigraphy.
Topics: Adult; Biopsy; Chi-Square Distribution; Contrast Media; Female; Humans; Inflammatory Bowel Diseases; | 2011 |